# A Study to Evaluate ENERGI-F705 Tablets in Healthy Volunteers

> **NCT07650383** · PHASE1 · COMPLETED · sponsor: **Energenesis Biomedical Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Health Adult Subjects

## Interventions

- **DRUG:** ENERGI-F705 Tablets 60 mg
- **DRUG:** ENERGI-F705 Tablets 120 mg
- **DRUG:** Vehicle Control

## Key facts

- **NCT ID:** NCT07650383
- **Lead sponsor:** Energenesis Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-24
- **Primary completion:** 2025-05-06
- **Final completion:** 2025-11-19
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650383, "A Study to Evaluate ENERGI-F705 Tablets in Healthy Volunteers". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07650383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*